Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,333 | 11,294 | 7,113 | 878 | 8,054 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,041 |
| Receivables | 5,633 | 1,741 | 579 | 528 | 162 |
| Inventories | 9,999 | 1,440 | 1,339 | 1,312 | 525 |
| Other current assets | 5,742 | 0 | 0 | 0 | 0 |
| TOTAL | $75,422 | $15,433 | $9,470 | $3,029 | $10,120 |
| Non-Current Assets | |||||
| PPE Net | 259 | 204 | 219 | 647 | 231 |
| Intangibles | 76,945 | 19,083 | 11,366 | 11,320 | 13,775 |
| Other Non-Current Assets | 667 | 2 | 5 | 3 | 216 |
| TOTAL | $77,871 | $19,289 | $11,590 | $11,970 | $14,223 |
| Total Assets | $153,293 | $34,721 | $21,060 | $14,999 | $24,343 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,322 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 11,640 | 2,134 | 2,120 | 2,220 | 2,323 |
| Accrued Expenses | 11,948 | 2,161 | 727 | 1,122 | 2,398 |
| Other current liabilities | 1,553 | 1,078 | 549 | 268 | 4 |
| TOTAL | $28,763 | $5,373 | $3,395 | $3,611 | $10,104 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,172 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 18,343 | 22,261 | 4,241 | 7,388 | 4,153 |
| TOTAL | $29,515 | $22,261 | $4,241 | $7,388 | $4,153 |
| Total Liabilities | $58,278 | $27,634 | $7,636 | $10,999 | $14,258 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 629 | 88 | 9 | 1 | 0 |
| Common Shares | 1 | 2 | 0 | 0 | 0 |
| Retained earnings | -120,010 | -106,390 | -79,258 | -69,070 | -46,561 |
| TOTAL | $95,015 | $7,088 | $13,425 | $4,000 | $10,085 |
| Total Liabilities And Equity | $153,293 | $34,721 | $21,060 | $14,999 | $24,343 |